The global biosimilars market is projected to experience significant growth over the next several years, according to a report from TechNavio.
The report, Global Biosimilars Market 2014-2018, says several factors could influence a projected compound annual growth rate of 27.58% in the global biologics market through 2018. The catalyst for the expected boom is an increasing number of expiring patents.
Blockbuster drugs whose patents are due to expire include Remicade, Humira, and Retuxan.
The report also notes that the risk of drug failure after launch is a key challenge for companies involved in the development of biosimilar drugs.
The full report is available through Research and Markets.
About the Author
Davy James is the associate editor of Specialty Pharmacy Times. He can be reached at email@example.com.